A new study titled "Goldilocks-Inspired Design of Mid-Size Macrocycles for Selective Targeting of Human Melanocortin Receptors" was published on June 24, 2026. The publication appears in the Journal of Medicinal Chemistry.
The study relates to melanocortin receptor targeting, a receptor class associated with PT-141 in research contexts. PT-141 remains classified as an unapproved research compound.
The publication is indexed under PubMed ID 42340853. No findings, efficacy data, or safety conclusions from the study are described in the available event information.
This brief reports only that the publication has occurred and where it appears. Readers seeking details on study design, results, or conclusions should consult the original source directly.
For additional background on PT-141 and its research classification, readers can refer to the compound overview.